KLH conjugated Synthetic peptide corresponding to Mouse LYRIC
Isotype
IgG
Purity
Affinity purification
Subcellular location
Nucleus, Cytoplasm, Cell Membrane
Predicted MW.
64 kDa
Observed MW.
75 kDa
Uniprot ID
Q86UE4, Q80WJ7, Q9Z1W6
Applications
Applications
Species
Dilution
Positive Sample
WB
Human, Mouse, Rat
1: 500-1: 1000
heart, brain
Background
LYRIC
protein also known as astrocyte elevated gene-1 protein (AEG-1). It is
involved in HIF-1alpha mediated angiogenesis. AEG-1 also interacts with
SND1 and involved in RNA-induced silencing complex (RISC) and plays very
important role in RISC and miRNA functions. AEG-1 induces an oncogene
called Late SV40 factor (LSF/TFCP2) which is involved in thymidylate
synthase (TS) induction and DNA biosynthesis synthesis. Late SV40 factor
enhances angiogenesis by transcriptionally up-regulating matrix
metalloproteinase-9 (MMP9). AEG-1 acts as an oncogene in melanoma,
malignant glioma, breast cancer and hepatocellular carcinoma. It is
highly expressed in these cancers and helps in progression and
development of these cancers. It is induced by c-Myc oncogene and plays
very important role in anchorage independent growth of cancer cells.
Images
Western blot analysis of LYRIC (GB111005) at dilution of 1: 500
Storage
Storage
Store at -20 ℃ for one year. Avoid repeated freeze/ thaw cycles.
Storage Buffer
PBS with 0.02% sodium azide, 100 μg/ml BSA and 50% glycerol.
NOTE:
1.This product is intended for research only.
2.This product is recommended to dilute with the Primary Antibody Dilution Buffer .